Deberza tablets 20mg

Deberza tablets 20mg (YJ_code: 3969021F1032, standard: 20mg 1 tablet) from Kowa contains tofogliflozin hydrate, an SGLT2 inhibitor approved in Japan for type 2 diabetes. It works by selectively inhibiting SGLT2 in the kidneys, reducing glucose reabsorption and increasing glucose excretion in the urine, with additional benefits such as mild weight loss and blood pressure reduction.